Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 74.50
0.00 (0.00%)
Sep 11, 2026, 5:00 PM CET
WSE:CTX Market Cap
WSE:CTX has a market cap or net worth of 473.33 million as of September 11, 2026. Its market cap has increased by 139.14% in one year.
Market Cap
473.33M
Enterprise Value
458.63M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.50
ChartMarket Cap Chart
Since April 19, 2021, WSE:CTX's market cap has decreased from 749.17M to 473.33M, a decrease of -36.82%. That is a compound annual growth rate of -8.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 473.33M | 18.91% |
| Dec 30, 2025 | 398.07M | 101.82% |
| Dec 30, 2024 | 197.24M | -57.12% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 576.12M |
| Bioceltix | 425.98M |
| Ryvu Therapeutics | 401.37M |
| BIOTON | 324.14M |
| Synthaverse | 223.90M |
| Molecure | 140.10M |
| Poltreg | 132.53M |
| Mabion | 126.23M |